FindTrial
Sign In

Treatment degenerative lumbar disease by lateral interbody fusion and navigation percutaneous screw fixation

Comparative study of OLIF with navigation percutaneous screw fixation and open surgery therapeutic effect on degenerative spondylolisthesis,degenerative lumbar scoliosis,lumbar spinal stenosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016701
Enrollment
Unknown
Registered
2018-06-18
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative spondylolisthesis,degenerative lumbar scoliosis,lumbar spinal stenosis

Interventions

group A1:degenerative lumbar spondylolisthesis treatment by OLIF and navigation percutaneous screw fixation
group A2:degenerative lumbar spondylolisthesis treatment by open surgery
group B1:degenerative lumbar scoliosis treatment by OLIF and navigation percutaneous screw fixation
group B2:degenerative lumbar scoliosis treatment by open surgery
group C1:lumbar spinal stenosis treatment by OLIF and navigation percutaneous screw fixation
group C2:lumbar spinal stenosis treatment by open surgery

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) patients aged 30-70 years, without gender limitation, are willing to sign informed consent; 2) patients diagnosed with degenerative spondylolisthesis(I-II degree), degenerative lumbar scoliosis, lumbar spinal stenosis; 3) patients with lower limbs radiating pain and numbness, intermittent claudication symptoms, conservative treatment 3 months is invalid or gradually increased.

Exclusion criteria

Exclusion criteria: 1. lumbar history of trauma and surgery; 2. accompanied by spinal tumour,infection and thoracolumbar nerve compression; 3. accompanied by nucleus pulposus extrusion or sequestrated disc; 4. poor health condition, unable to tolerate surgery; 5. patients can not give full informed consent for adult dysfunction; 6. patients who have participated in other clinical trials in the past 1 month; 7. patients with active hepatitis B (including HBeAg) or serological markers (HBsAg or / and HBeAg or / and HBcAb), hepatitis C, tuberculosis, cytomegalovirus infection, severe fungal infection, HIV infection or patients with Turmor.

Design outcomes

Primary

MeasureTime frame
ODI score;neuroforamen height;neuroforamen area;spinal canal area;complication;—

Secondary

MeasureTime frame
VAS score;JOA score;SF-36 score;ROM of surgery ROM;disc space height;—

Countries

China

Contacts

Public ContactXiaojian Ye

Changzheng Hospital

yexj2002@163.com+86 021-81885624

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026